These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30132016)

  • 1. Cross talk between natural killer cells and mast cells in tumor angiogenesis.
    Ribatti D; Tamma R; Crivellato E
    Inflamm Res; 2019 Jan; 68(1):19-23. PubMed ID: 30132016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
    Bruno A; Mortara L; Baci D; Noonan DM; Albini A
    Front Immunol; 2019; 10():771. PubMed ID: 31057536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast Cells and Natural Killer Cells-A Potentially Critical Interaction.
    Portales-Cervantes L; Dawod B; Marshall JS
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31167464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
    Albini A; Bruno A; Noonan DM; Mortara L
    Front Immunol; 2018; 9():527. PubMed ID: 29675018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of chemokines in the biology of natural killer cells.
    Maghazachi AA
    Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.
    Bruno A; Ferlazzo G; Albini A; Noonan DM
    J Natl Cancer Inst; 2014 Aug; 106(8):dju200. PubMed ID: 25178695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases.
    Radomska-Leśniewska DM; Białoszewska A; Kamiński P
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell contribution to tumor angiogenesis: a clinical approach.
    Crivellato E; Nico B; Ribatti D
    Eur Cytokine Netw; 2009 Dec; 20(4):197-206. PubMed ID: 20167559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.
    Wallace ME; Smyth MJ
    Springer Semin Immunopathol; 2005 Jun; 27(1):49-64. PubMed ID: 15729567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells and solid tumors.
    Stojanovic A; Cerwenka A
    J Innate Immun; 2011; 3(4):355-64. PubMed ID: 21502747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells, angiogenesis, and tumour growth.
    Ribatti D; Crivellato E
    Biochim Biophys Acta; 2012 Jan; 1822(1):2-8. PubMed ID: 21130163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells: the journey from puzzles in biology to treatment of cancer.
    Bodduluru LN; Kasala ER; Madhana RM; Sriram CS
    Cancer Lett; 2015 Feb; 357(2):454-67. PubMed ID: 25511743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells and tumor metastasis.
    Lee HH; Kang H; Cho H
    Arch Pharm Res; 2017 Sep; 40(9):1037-1049. PubMed ID: 28871566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis.
    Ribatti D
    Immunol Lett; 2013 May; 152(2):83-8. PubMed ID: 23685256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell-directed therapies: moving from unexpected results to successful strategies.
    Terme M; Ullrich E; Delahaye NF; Chaput N; Zitvogel L
    Nat Immunol; 2008 May; 9(5):486-94. PubMed ID: 18425105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mast cells in tumor growth.
    Conti P; Castellani ML; Kempuraj D; Salini V; Vecchiet J; Tetè S; Mastrangelo F; Perrella A; De Lutiis MA; Tagen M; Theoharides TC
    Ann Clin Lab Sci; 2007; 37(4):315-22. PubMed ID: 18000287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies.
    Bhat R; Watzl C
    PLoS One; 2007 Mar; 2(3):e326. PubMed ID: 17389917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.
    Vosskuhl K; Greten TF; Manns MP; Korangy F; Wedemeyer J
    J Immunol; 2010 Jul; 185(1):119-25. PubMed ID: 20511546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.